Three to Tango: MUC1 As a Ligand for Both E-Selectin and ICAM-1 in the Breast Cancer Metastatic Cascade
Overview
Affiliations
CANCER CELL TETHERING AND ROLLING ON THE VASCULAR WALL IS FACILITATED BY VARIOUS SELECTIN: glycoprotein interactions which lead to eventual extravasation and metastases. The aberrantly underglycosylated mucin MUC1 has been shown to both abundantly express selectin binding moieties (sialyl Lewis x and a) and to consistently expose its core epitope. Flow cytometry was used to determine MUC1 expression on ZR-75-1 and MCF7 cells, while immunofluorescence microscopy was used to confirm the aberrant form of MUC1 and MUC1:ICAM-1 interactions. Each cell line was then perfused through combined E-selectin and ICAM-1 coated microtubes, as a model of the microvascular endothelium. ZR-75-1 and MCF7 were found to express abundant and low levels of underglycosylated MUC1, respectively. The rolling/adhesion profiles showed that ZR-75-1 cells, when compared to MCF7 cells, interact with E-selectin more efficiently resulting in sufficiently slow rolling velocities to form MUC1:ICAM-1 interactions thereby facilitating firm adhesion. The purpose and novelty of this work is the demonstration of the synergistic adhesion capabilities of MUC1 in the metastatic adhesion cascade, where the observed differential adhesion is consistent with the relative metastatic potential of the ZR-75-1 (highly metastatic) and MCF7 (weakly metastatic) cell lines.
Breaking boundaries: role of the brain barriers in metastatic process.
Izadi N, Solar P, Hasanova K, Zamani A, Akbar M, Mrazova K Fluids Barriers CNS. 2025; 22(1):3.
PMID: 39780275 PMC: 11708195. DOI: 10.1186/s12987-025-00618-z.
Research progress of MUC1 in genitourinary cancers.
Mao W, Zhang H, Wang K, Geng J, Wu J Cell Mol Biol Lett. 2024; 29(1):135.
PMID: 39491020 PMC: 11533421. DOI: 10.1186/s11658-024-00654-x.
Bulky glycocalyx drives cancer invasiveness by modulating substrate-specific adhesion.
Barai A, Piplani N, Saha S, Dutta S, Gomathi V, Ghogale M PNAS Nexus. 2024; 3(8):pgae335.
PMID: 39211517 PMC: 11358709. DOI: 10.1093/pnasnexus/pgae335.
Mucin1 as a potential molecule for cancer immunotherapy and targeted therapy.
Tong X, Dong C, Liang S J Cancer. 2024; 15(1):54-67.
PMID: 38164273 PMC: 10751670. DOI: 10.7150/jca.88261.
Alsabbagh R, Ahmed M, Alqudah M, Hamoudi R, Harati R Cancers (Basel). 2023; 15(8).
PMID: 37190188 PMC: 10137309. DOI: 10.3390/cancers15082258.